Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

tics/pykinimas

Nuoroda įrašoma į mainų sritį
Puslapis 1 nuo 30 rezultatus

Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
OBJECTIVE To test the hypothesis that atomoxetine does not significantly worsen tic severity relative to placebo in children and adolescents with attention deficit/hyperactivity disorder (ADHD) and comorbid tic disorders. METHODS Study subjects were 7 to 17 years old, met Diagnostic and Statistical

Safety of aripiprazole for tics in children and adolescents: A systematic review and meta-analysis.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Aripiprazole is widely used in the management of tic disorders (TDs), we aimed to assess the safety of aripiprazole for TDs in children and adolescents.A systematic literature review was performed in the databases of MEDLINE, Embase, the Cochrane Library

An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
OBJECTIVE This study aimed to investigate the efficacy and tolerability of aripiprazole, an atypical antipsychotic with dual agonist and antagonist actions toward dopaminergic imbalance and partial serotonin-2A receptor antagonism, for treating children and adolescents with tic

Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Tourette syndrome is a childhood-onset chronic tic disorder characterized by multiple motor and vocal tics and often accompanied by specific behavioral symptoms ranging from obsessionality to impulsivity. A considerable proportion of patients report significant impairment in health-related quality
The aims are to evaluate the efficacy and safety of aripiprazole for tic disorders (TDs) in children and adolescents. We searched PubMed, Embase, PsychINFO, Cochrane database as well as Chinese databases of CNKI, VIP, CBM and Wanfang from the database inception to October 2016, and 17 full-text

Aripiprazole for the treatment of tic disorders in children: a systematic review and meta-analysis.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND Tic disorders (TDs) are common neuropsychiatric disorders in children. Typical antipsychotics, such as haloperidol and pimozide have been prescribed to control tic symptoms as first-line agents. However, adverse effects have led to the use of newer atypical antipsychotics. Aripiprazole is
dl-threo-Methylphenidate is a highly efficacious drug for treating attention-deficit hyperactivity disorder (ADHD) that is currently administered as immediate- or controlled-release and osmotically controlled-released formulations. The drug exists as two enantiomers, d-threo-methylphenidate and

Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Nicotine was found to markedly potentiate haloperidol-induced hypokinesia in rats. Nicotine alone was without effect. Subsequently, concurrent administration of 2 mg nicotine gum to 10 Tourette syndrome patients being treated with haloperidol produced a substantial decrease in tics and improvement

Rapid intravenous loading of levodopa for human research: clinical results.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Levodopa has several advantages as a pharmacological challenge agent for human neuroscience research. Exogenous levodopa changes striatal neuronal activity and increases extracellular dopamine concentrations, and with adequate inhibition of peripheral metabolism levodopa does not change mean

Cannabis and neuropsychiatry, 1: benefits and risks.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Cannabis is popularly believed to be a relatively benign substance. Cannabis is also considered to have potential medical benefits, and medical marijuana has been legislated in many parts of the world. However, a recent meta-analysis found that cannabinoids were associated with only modest benefits

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Atomoxetine (Strattera(R)) is a selective norepinephrine (noradrenaline) reuptake inhibitor that is not classified as a stimulant, and is indicated for use in patients with attention-deficit hyperactivity disorder (ADHD). Atomoxetine is effective and generally well tolerated. It is significantly

Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Attention-deficit hyperactivity disorder (ADHD) is one of the most common neurobehavioural disorders in children. It has been shown that as many as 85% of patients with ADHD have at least one psychiatric co-morbidity, and approximately 60% have at least two. Atomoxetine is a specific, noradrenergic

Efficacy and safety of acupuncture in children: an overview of systematic reviews.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
In recent years, acupuncture has increasingly being integrated into pediatric health care. It was used on ~150,000 children (0.2%). We aim to update the evidence for the efficacy and safety of acupuncture for children and evaluate the methodological qualities of these studies to improve future

Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
OBJECTIVE Paroxetine is a selective serotonin reuptake inhibitor with demonstrated efficacy in treating obsessive-compulsive disorder (OCD) in adults. This study evaluates the safety and effectiveness of paroxetine in pediatric OCD patients. METHODS In a 12-week, open-label trial of paroxetine, 20

Diagnosis and management of migraine headaches.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Migraine headaches afflict approximately 6% of men and 18% of women in the United States, and cost billions of dollars each year in lost productivity, absenteeism, and direct medical expendi tures. Despite its prevalence and the availability of therapeutic op tions, many patients do not seek
Prisijunkite prie mūsų
„Facebook“ puslapio

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

  • Dirba 55 kalbomis
  • Žolelių gydymas, paremtas mokslu
  • Vaistažolių atpažinimas pagal vaizdą
  • Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
  • Skaitykite mokslines publikacijas, susijusias su jūsų paieška
  • Ieškokite vaistinių žolelių pagal jų poveikį
  • Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais

Google Play badgeApp Store badge